Total global prescription drug revenue from top 10 companies 2024

In 2024, Pfizer is expected to generate over 51 billion U.S. dollars’ worth of prescription drug revenue, making it the pharmaceutical company with the highest projected Rx drug-based revenue for that specific year. With approximately 50 billion U.S. dollars, Novartis AG is forecast to stand in second place.

GSK

GlaxoSmithKline plc, a British enterprise, based in Brentford, United Kingdom, is one of Europe’s largest pharmaceutical companies. GSK is projected to generate about 39 billion U.S. dollars’ worth of Rx drug revenue in 2024, putting the company in seventh place for that period. In terms of total revenue, they generated close to 31 billion U.S. dollars in 2018, which was the highest revenue amount the company had made between 2006 and 2018.

European pharmaceutical industry

The top ten list based on projected Rx drug revenue included other European pharma companies, such as Sanofi, Roche, and AstraZeneca. In terms of both retail sales and R&D (research & development) spending, the Swiss Roche AG was the European leader in 2018. That year, the pharmaceutical giant generated sales figures of approximately 44 and a half billion U.S. dollars and spent just under ten billion U.S. dollars on R&D.